138 related articles for article (PubMed ID: 8470634)
1. Nifedipine for suspected type II sphincter of Oddi dyskinesia.
Sand J; Nordback I; Koskinen M; Matikainen M; Lindholm TS
Am J Gastroenterol; 1993 Apr; 88(4):530-5. PubMed ID: 8470634
[TBL] [Abstract][Full Text] [Related]
2. Nifedipine for suspected type II sphincter of Oddi dyskinesia.
Khuroo MS; Yattoo GN; Khan BA; Altaf HS; Syed-ur-Rehman
Am J Gastroenterol; 1994 Jul; 89(7):1122-3. PubMed ID: 8017386
[No Abstract] [Full Text] [Related]
3. [Management of hypertensive dyskinesia of Oddi's sphincter. Correlation between the frequency of complications from endoscopic sphincterotomy and the diameter of the common bile duct].
Simon L; Döbrönte Z; Patai A
Orv Hetil; 1995 Jul; 136(31):1659-62. PubMed ID: 7637986
[TBL] [Abstract][Full Text] [Related]
4. The utility of liver function test abnormalities concomitant with biliary symptoms in predicting a favorable response to endoscopic sphincterotomy in patients with presumed sphincter of Oddi dysfunction.
Lin OS; Soetikno RM; Young HS
Am J Gastroenterol; 1998 Oct; 93(10):1833-6. PubMed ID: 9772040
[TBL] [Abstract][Full Text] [Related]
5. Suspected sphincter of Oddi dysfunction type II: empirical biliary sphincterotomy or manometry-guided therapy?
Arguedas MR; Linder JD; Wilcox CM
Endoscopy; 2004 Feb; 36(2):174-8. PubMed ID: 14765316
[TBL] [Abstract][Full Text] [Related]
6. Effects of vardenafil, a phosphodiesterase type-5 inhibitor, on sphincter of Oddi motility in patients with suspected biliary sphincter of Oddi dysfunction.
Cheon YK; Cho YD; Moon JH; Im HH; Jung Y; Lee JS; Lee MS; Shim CS
Gastrointest Endosc; 2009 May; 69(6):1111-6. PubMed ID: 19243765
[TBL] [Abstract][Full Text] [Related]
7. Slow release nifedipine for patients with sphincter of Oddi dyskinesia: results of a pilot study.
Craig AG; Toouli J
Intern Med J; 2002 Mar; 32(3):119-20. PubMed ID: 11885840
[No Abstract] [Full Text] [Related]
8. Botulinum toxin injection after biliary sphincterotomy.
Gorelick A; Barnett J; Chey W; Anderson M; Elta G
Endoscopy; 2004 Feb; 36(2):170-3. PubMed ID: 14765315
[TBL] [Abstract][Full Text] [Related]
9. [Therapy of dyskinesia of Oddiś sphincter with calcium antagonists].
Simon L; Kovács S
Orv Hetil; 1983 Nov; 124(46):2805-9. PubMed ID: 6646746
[No Abstract] [Full Text] [Related]
10. Incomplete response to endoscopic sphincterotomy in patients with sphincter of Oddi dysfunction: evidence for a chronic pain disorder.
Linder JD; Klapow JC; Linder SD; Wilcox CM
Am J Gastroenterol; 2003 Aug; 98(8):1738-43. PubMed ID: 12907327
[TBL] [Abstract][Full Text] [Related]
11. Nifedipine is not feasible for biliary pain in patients with gallbladder stones.
Sand JA; Frey T; Malminiemi K; Nordback IH
Int J Clin Pharmacol Ther; 1999 Dec; 37(12):608-12. PubMed ID: 10599953
[TBL] [Abstract][Full Text] [Related]
12. Incidence of pancreatitis in patients undergoing sphincter of Oddi manometry (SOM).
Maldonado ME; Brady PG; Mamel JJ; Robinson B
Am J Gastroenterol; 1999 Feb; 94(2):387-90. PubMed ID: 10022634
[TBL] [Abstract][Full Text] [Related]
13. Transduodenal sphincteroplasty and transampullary septectomy for sphincter of Oddi dysfunction.
Tzovaras G; Rowlands BJ
Ann R Coll Surg Engl; 2002 Jan; 84(1):14-9. PubMed ID: 11890620
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial.
Khuroo MS; Zargar SA; Yattoo GN
Br J Clin Pharmacol; 1992 May; 33(5):477-85. PubMed ID: 1524959
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic manometry of the sphincter of Oddi in sphincterotomized patients.
Ugljesić M; Bulajić M; Milosavljević T; Stimec B
Hepatogastroenterology; 1995; 42(4):348-51. PubMed ID: 8586366
[TBL] [Abstract][Full Text] [Related]
16. Intrasphincteric botulinum toxin type A for the diagnosis of sphincter of Oddi dysfunction: a case report.
Banerjee B; Miedema B; Saifuddin T; Marshall JB
Surg Laparosc Endosc Percutan Tech; 1999 Jun; 9(3):194-6. PubMed ID: 10803999
[TBL] [Abstract][Full Text] [Related]
17. Role of prophylactic endoscopic sphincterotomy in patients with acute biliary pancreatitis due to transient common bile duct obstruction.
Teoh AY; Poon MC; Leong HT
J Gastroenterol Hepatol; 2007 Sep; 22(9):1415-8. PubMed ID: 17645462
[TBL] [Abstract][Full Text] [Related]
18. Effect of endoscopic sphincterotomy on sphincter of Oddi manometry results in patients with or without papillary stenosis.
Wehrmann T; Wiemer K; Lembcke B; Jung M
Z Gastroenterol; 1995 Nov; 33(11):662-8. PubMed ID: 8600663
[TBL] [Abstract][Full Text] [Related]
19. Influence of endoscopic papillary balloon dilation and endoscopic sphincterotomy on sphincter of oddi function: a randomized controlled trial.
Takezawa M; Kida Y; Kida M; Saigenji K
Endoscopy; 2004 Jul; 36(7):631-7. PubMed ID: 15243887
[TBL] [Abstract][Full Text] [Related]
20. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction.
Freeman ML; Gill M; Overby C; Cen YY
J Clin Gastroenterol; 2007 Jan; 41(1):94-102. PubMed ID: 17198071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
